2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation

Integrated Care and Outcomes in Patients with Atrial Fibrillation and Comorbidities

(2021) Marco Proietti et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Non‐vitamin K antagonist oral anticoagulants versus warfarin in AF patients ≥ 85 years

(2021) Chuan‐Tsai Tsai et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Predictors of ischemic stroke for low-risk patients with atrial fibrillation: A matched case-control study

(2021) Soonil Kwon et al.   HEART RHYTHM

Non–Vitamin K Antagonist Oral Anticoagulants in Elderly (≥85 years) Patients With Newly Diagnosed Atrial Fibrillation

(2021) Wen-Han Cheng et al.   MAYO CLINIC PROCEEDINGS

Off-label underdosed apixaban use in Asian patients with non-valvular atrial fibrillation

(2021) So-Ryoung Lee et al.   European Heart Journal-Cardiovascular Pharmacotherapy

Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation

(2021) Tze-Fan Chao et al.   Clinical Research in Cardiology

Oral Anticoagulants in Extremely High Risk Very Elderly (>90 years) Patients with Atrial Fibrillation

(2021) Tze-Fan Chao et al.   HEART RHYTHM

Body Mass Index and Clinical Outcomes in Asian Patients With Atrial Fibrillation Receiving Oral Anticoagulation

(2021) So-Ryoung Lee et al.   STROKE

Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: is it time to reconsider our therapeutic strategy?

(2021) Panteleimon E Papakonstantinou et al.   European Journal of Preventive Cardiology

Device-Related Thrombus After Left Atrial Appendage Closure: Data on Thrombus Characteristics, Treatment Strategies, and Clinical Outcomes From the EUROC-DRT-Registry

(2021) Alexander Sedaghat et al.   Circulation-Cardiovascular Interventions

Alcohol Abstinence and the Risk of Atrial Fibrillation in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: A Nationwide Population-Based Study

(2021) You-jung Choi et al.   DIABETES CARE

Characteristics and clinical outcomes in atrial fibrillation patients classified using cluster analysis: the Fushimi AF Registry

(2021) Hisashi Ogawa et al.   EUROPACE

Incident atrial fibrillation and its risk prediction in patients developing COVID-19: A machine learning based algorithm approach

(2021) Gregory Y.H. Lip et al.   European Journal of Internal Medicine

Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology

(2021) Giuseppe Boriani et al.   European Journal of Internal Medicine

Association of cardiovascular health and incident atrial fibrillation in elderly population

(2021) Jae-Hyuk Lee et al.   HEART

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit

(2021) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19

(2021) Azita H. Talasaz et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial

(2021) An S. De Vriese et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke

(2021) Richard P. Whitlock et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 vaccine and thrombosis: Expert opinions

(2021) Ismail Elalamy et al.   THROMBOSIS AND HAEMOSTASIS

Optimal Management of Anticoagulation Therapy in Asian Patients With Atrial Fibrillation

(2021) Wen-Han Cheng et al.   CIRCULATION JOURNAL

The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review

(2021) David Stevens et al.   EUROPACE

A meta-analysis of clinical risk factors for stroke in anticoagulant-naïve patients with atrial fibrillation

(2021) Jean Jacques Noubiap et al.   EUROPACE

Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial

(2021) Renato D Lopes et al.   LANCET

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

(2021)   NEW ENGLAND JOURNAL OF MEDICINE

The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper

(2021) Grigoris T. Gerotziafas et al.   THROMBOSIS AND HAEMOSTASIS

Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes

(2021) José Miguel Rivera-Caravaca et al.   THROMBOSIS RESEARCH

Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: A nationwide population-based cohort study

(2021) Hyo-Jeong Ahn et al.   PLOS MEDICINE

Exercise and the Risk of Dementia in Patients with Newly Diagnosed Atrial Fibrillation: A Nationwide Population-Based Study

(2021) Jaehyun Lim et al.   Journal of Clinical Medicine

Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis

(2021) Giulio Francesco Romiti et al.   Journal of Clinical Medicine

Comparison of HAS-BLED and ORBIT Bleeding Risk Scores in AF Patients treated with NOACs: A Report from the ESC-EHRA EORP-AF General Long-Term Registry

(2021) Marco Proietti et al.   European Heart Journal-Quality of Care and Clinical Outcomes

Targeted atrial fibrillation detection in COVID-19 vaccination clinics

(2021) Gary A Ford et al.   European Heart Journal-Quality of Care and Clinical Outcomes

Improving dynamic stroke risk prediction in non-anticoagulated patients with and without atrial fibrillation: comparing common clinical risk scores and machine learning algorithms

(2021) Gregory Y H Lip et al.   European Heart Journal-Quality of Care and Clinical Outcomes

Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study

(2021) S R Lee et al.   EUROPEAN HEART JOURNAL

Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Dialysis

(2020) Toshiki Kuno et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

(2020) Arjun K. Pandey et al.   THROMBOSIS AND HAEMOSTASIS

Should We Adopt a Standard International Normalized Ratio Range of 2.0 to 3.0 for Asian Patients with Atrial Fibrillation? An Appeal for Evidence-Based Management, Not Eminence-Based Recommendations

(2020) Tze-Fan Chao et al.   THROMBOSIS AND HAEMOSTASIS

Thromboembolism and bleeding complications in anticoagulated patients with atrial fibrillation and native aortic or mitral valvular heart disease: a descriptive nationwide cohort study

(2020) Line Melgaard et al.   European Heart Journal-Cardiovascular Pharmacotherapy

Regular Bleeding Risk Assessment Associated with Reduction in Bleeding Outcomes: The mAFA-II Randomized Trial

(2020) Yutao Guo et al.   AMERICAN JOURNAL OF MEDICINE

Risks and Outcomes of Gastrointestinal Malignancies in Anticoagulated Atrial Fibrillation Patients Experiencing Gastrointestinal Bleeding – A Nationwide Cohort Study

(2020) Ting-Yung Chang et al.   HEART RHYTHM

Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation

(2020) Yutao Guo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

(2020) Behnood Bikdeli et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Female Sex as a Risk Modifier for Stroke Risk in Atrial Fibrillation: Using CHA2DS2-VASc versus CHA2DS2-VA for Stroke Risk Stratification in Atrial Fibrillation: A Note of Caution

(2020) Peter Brønnum Nielsen et al.   THROMBOSIS AND HAEMOSTASIS

Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research

(2020) Mahesh V. Madhavan et al.   THROMBOSIS AND HAEMOSTASIS

Incident Comorbidities, Aging and the Risk of Stroke in 608,108 Patients with Atrial Fibrillation: A Nationwide Analysis

(2020) Laurent Fauchier et al.   Journal of Clinical Medicine

The Effect of Integrated Care Management on Dementia in Atrial Fibrillation

(2020) Pil-Sung Yang et al.   Journal of Clinical Medicine

Off-label dosing of non–vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation

(2020) Yi-Hsin Chan et al.   HEART RHYTHM

Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation

(2020) Pavel Osmancik et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project

(2020) Anny Camelo-Castillo et al.   THROMBOSIS AND HAEMOSTASIS

Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation

(2020) Hee Tae Yu et al.   Journal of the American Heart Association

Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non–vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage

(2020) Chuan-Tsai Tsai et al.   JAMA Network Open

Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry

(2020) Marco Proietti et al.   EUROPACE

Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort

(2020) Yutao Guo et al.   European Journal of Internal Medicine

Impacts of Different Renal Function Estimation Formulas on Dosing of DOACs and Clinical Outcomes

(2020) Yi-Hsin Chan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19

(2020) Girish N. Nadkarni et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Prognostic Value of Electrocardiogram at Presentation to Emergency Department in Patients With COVID-19

(2020) Pierre Elias et al.   MAYO CLINIC PROCEEDINGS

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

(2020) Ken Okumura et al.   NEW ENGLAND JOURNAL OF MEDICINE

Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 Trial

(2020) Giuseppe Boriani et al.   THROMBOSIS AND HAEMOSTASIS

Long-term PM2.5 exposure and the clinical application of machine learning for predicting incident atrial fibrillation

(2020) In-Soo Kim et al.   Scientific Reports

Protocol, rationale and design of DAbigatran for Stroke PreVention In Atrial Fibrillation in MoDerate or Severe Mitral Stenosis (DAVID-MS): a randomised, open-label study

(2020) Mi Zhou et al.   BMJ Open

Evaluation of Remote Pharmacist-Led Outpatient Service for Geriatric Patients on Rivaroxaban for Nonvalvular Atrial Fibrillation During the COVID-19 Pandemic

(2020) Xiaoye Li et al.   Frontiers in Pharmacology

Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis

(2020) Lai-Chu See et al.   CARDIOVASCULAR DRUGS AND THERAPY

Effect of alcohol consumption on the risk of adverse events in atrial fibrillation: from the COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF) registry

(2020) Chewan Lim et al.   EUROPACE

Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal

(2020) Deirdre A Lane et al.   EUROPEAN HEART JOURNAL SUPPLEMENTS

Reduction in all-cause mortality in COVID-19 patients on chronic oral anticoagulation: A population-based propensity score matched study

(2020) Gentian Denas et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores

(2020) José Miguel Rivera-Caravaca et al.   THROMBOSIS AND HAEMOSTASIS

ABC (Atrial fibrillation Better Care) pathway and healthcare costs in atrial fibrillation. The ATHERO-AF study

(2019) Daniele Pastori et al.   AMERICAN JOURNAL OF MEDICINE

Reassessment of Risk for Stroke During Follow-up of Patients With Atrial Fibrillation

(2019) Tze-Fan Chao et al.   ANNALS OF INTERNAL MEDICINE

Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study

(2019) Jiesuck Park et al.   PLoS One

Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study

(2019) Hyunjean Jung et al.   THROMBOSIS AND HAEMOSTASIS

Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review

(2019) Danai Bem et al.   THROMBOSIS AND HAEMOSTASIS

Recommendations on stroke prevention for patients having a CHA2DS2-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines

(2019) Tze-Fan Chao et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Incident Co-Morbidities in Patients with Atrial Fibrillation Initially with a CHA2DS2-VASc Score of 0 (Males) or 1 (Females): Implications for Reassessment of Stroke Risk in Initially ‘Low-Risk’ Patients

(2019) Tze-Fan Chao et al.   THROMBOSIS AND HAEMOSTASIS

Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function

(2019) So-Ryoung Lee et al.   STROKE

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

(2019) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

(2019) Renato D. Lopes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Body Mass Index Variability and Long-term Risk of New-Onset Atrial Fibrillation in the General Population: A Korean Nationwide Cohort Study

(2019) Yeong-Min Lim et al.   MAYO CLINIC PROCEEDINGS

Outcomes of Direct Oral Anticoagulants in Patients With Mitral Stenosis

(2019) Ju Youn Kim et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight

(2019) So-Ryoung Lee et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial

(2019) Jonas Oldgren et al.   EUROPEAN HEART JOURNAL

Importance of risk reassessment in patients with atrial fibrillation in guidelines: Assessing risk as a dynamic process

(2019) Ting-Yung Chang et al.   CANADIAN JOURNAL OF CARDIOLOGY

Effectiveness and Safety of Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation Patients with Severe Kidney Disease or Undergoing Hemodialysis

(2019) Craig I. Coleman et al.   AMERICAN JOURNAL OF MEDICINE

Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology

(2019) Lucas V. Boersma et al.   Circulation-Arrhythmia and Electrophysiology

Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial

(2019) Stefan H Hohnloser et al.   EUROPEAN HEART JOURNAL

Major Adverse Events With Percutaneous Left Atrial Appendage Closure in Patients With Atrial Fibrillation

(2019) Laurent Fauchier et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF)

(2019) Hyeongsoo Kim et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation

(2019) So-Ryoung Lee et al.   AMERICAN JOURNAL OF CARDIOLOGY

Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight

(2019) Stefan H. Hohnloser et al.   CIRCULATION

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease

(2019) So-Ryoung Lee et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease

(2019) Arman Qamar et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation

(2019) Wen-Han Cheng et al.   STROKE

Novel Oral Anticoagulants for Primary Stroke Prevention in Hypertrophic Cardiomyopathy Patients With Atrial Fibrillation

(2019) Hyun-Jung Lee et al.   STROKE

Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study

(2019) Minjae Yoon et al.   THROMBOSIS AND HAEMOSTASIS

Cost‐Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5‐Year, Long‐Term Data

(2019) Vivek Y. Reddy et al.   Journal of the American Heart Association

Efficacy and Safety of Uninterrupted Periprocedural Edoxaban in Patients Undergoing Catheter Ablation for Atrial Fibrillation　― The Prospective KYU-RABLE Study ―

(2019) Naohiko Takahashi et al.   CIRCULATION JOURNAL

EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update

(2019) Michael Glikson et al.   EUROPACE

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial

(2019) Pascal Vranckx et al.   LANCET

Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease

(2019) Satoshi Yasuda et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal

(2019) María Asunción Esteve-Pastor et al.   THROMBOSIS AND HAEMOSTASIS

Global Use of Idarucizumab in Clinical Practice: Outcomes of the RE-VECTO Surveillance Program

(2019) John Fanikos et al.   THROMBOSIS AND HAEMOSTASIS

Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis

(2019) Yi-Hsin Chan et al.   CARDIOVASCULAR DRUGS AND THERAPY

The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients

(2019) Daehoon Kim et al.   EUROPACE

Bodyweight fluctuation is associated with increased risk of incident atrial fibrillation

(2019) Hyun-Jung Lee et al.   HEART RHYTHM

Dabigatran Reversal With Idarucizumab in Patients With Renal Impairment

(2019) John W. Eikelboom et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

NOAC Adherence of Patients with Atrial Fibrillation in the Real World: Dosing Frequency Matters?

(2019) Jongmin Hwang et al.   THROMBOSIS AND HAEMOSTASIS

Physical Activity and Risk of Atrial Fibrillation: A Nationwide Cohort Study in General Population

(2019) Moo-Nyun Jin et al.   Scientific Reports

Comparisons of Rivaroxaban Following Different Dosage Criteria (ROCKET AF or J‐ROCKET AF Trials) in Asian Patients With Atrial Fibrillation

(2019) Yi‐Hsin Chan et al.   Journal of the American Heart Association

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease

(2019) Moon et al.   Journal of Clinical Medicine

Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation

(2019) Tze-Fan Chao et al.   CHEST

Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage

(2019) So-Ryoung Lee et al.   STROKE

Effectiveness and Safety of Direct Oral Anticoagulant for Secondary Prevention in Asians with Atrial Fibrillation

(2019) Jiesuck Park et al.   Journal of Clinical Medicine

10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population

(2018) Daehoon Kim et al.   AMERICAN HEART JOURNAL

Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation

(2018) Yutao Guo et al.   AMERICAN JOURNAL OF MEDICINE

Lifetime Risks, Projected Numbers, and Adverse Outcomes in Asian Patients With Atrial Fibrillation

(2018) Tze-Fan Chao et al.   CHEST

Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States

(2018) Konstantinos C. Siontis et al.   CIRCULATION

Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation

(2018) Tze-Fan Chao et al.   CIRCULATION

PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study

(2018) Melissa E Middeldorp et al.   EUROPACE

Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events

(2018) Kohki Nakamura et al.   EUROPACE

Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation

(2018) Lien Desteghe et al.   EUROPEAN HEART JOURNAL

Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation

(2018) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

(2018) Jan Steffel et al.   EUROPEAN HEART JOURNAL

Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015

(2018) Daehoon Kim et al.   HEART

An updated meta-analysis of novel oral anticoagulants versus vitamin K antagonists for uninterrupted anticoagulation in atrial fibrillation catheter ablation

(2018) Rhanderson Cardoso et al.   HEART RHYTHM

A meta-analysis of randomized controlled trials of uninterrupted periprocedural anticoagulation strategy in patients undergoing atrial fibrillation catheter ablation

(2018) Yating Zhao et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Percutaneous Left Atrial Appendage Closure with WATCHMAN™ device: peri-procedural and mid-term outcomes from the TRAPS Registry

(2018) Patrizio Mazzone et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Oral Anticoagulation in Patients With Liver Disease

(2018) Arman Qamar et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Non–Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury

(2018) Antonios Douros et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation

(2018) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation

(2018) Laurent Fauchier et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Safety and efficacy of apixaban versus warfarin in patients with end-stage renal disease: Meta-analysis

(2018) Ronpichai Chokesuwattanaskul et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation

(2018) Tae-Hoon Kim et al.   STROKE

Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors

(2018) Tze-Fan Chao et al.   THROMBOSIS AND HAEMOSTASIS

Dynamic Changes of CHA2DS2-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study

(2018) Minjae Yoon et al.   THROMBOSIS AND HAEMOSTASIS

Antithrombotic Therapy for Atrial Fibrillation

(2018) Gregory Y.H. Lip et al.   CHEST

Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: A nationwide population-based study

(2018) You-Jung Choi et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Ideal Blood Pressure in Patients With Atrial Fibrillation

(2018) Daehoon Kim et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Efficacy and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study

(2018) Chun‐Li Wang et al.   Journal of the American Heart Association

Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy

(2018) Hyunjean Jung et al.   CHEST

Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan

(2018) Tze-Fan Chao et al.   CIRCULATION

Percutaneous WATCHMAN Left Atrial Appendage Closure for Japanese Patients With Nonvalvular Atrial Fibrillation at Increased Risk of Thromboembolism　― First Results From the SALUTE Trial ―

(2018) Kazutaka Aonuma et al.   CIRCULATION JOURNAL

Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial

(2018) Giuseppe Boriani et al.   EUROPEAN HEART JOURNAL

Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population

(2018) Tae-Hoon Kim et al.   EUROPEAN HEART JOURNAL

When is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation? A multicentre prospective randomized study

(2018) Hee Tae Yu et al.   EUROPEAN HEART JOURNAL

Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities

(2018) Tze-Fan Chao et al.   EUROPEAN HEART JOURNAL

Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial

(2018) Tze-Fan Chao et al.   EUROPEAN HEART JOURNAL

Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials

(2018) Kang-Ling Wang et al.   EUROPEAN HEART JOURNAL

Long-term exposure of fine particulate matter air pollution and incident atrial fibrillation in the general population: A nationwide cohort study

(2018) In-Soo Kim et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy

(2018) Hyunjean Jung et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events

(2018) Daniele Pastori et al.   MAYO CLINIC PROCEEDINGS

Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review

(2018) Ethan Borre et al.   THROMBOSIS AND HAEMOSTASIS

Modelling projections for the risks related with atrial fibrillation in East Asia: a focus on ischaemic stroke and death

(2017) Ying Bai et al.   EUROPACE

Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

(2017) Gregory Y H Lip et al.   EUROPACE

Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort study in Korea

(2017) Sean S. Lee et al.   EUROPEAN HEART JOURNAL

The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis

(2017) Justine Hum et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy

(2017) Sang-Eun Lee et al.   HEART

Increased risk of major bleeding in underweight patients with atrial fibrillation who were prescribed non-vitamin K antagonist oral anticoagulants

(2017) Chan Soon Park et al.   HEART RHYTHM

Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial

(2017) Lucas V. Boersma et al.   HEART RHYTHM

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

(2017) Hugh Calkins et al.   HEART RHYTHM

Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with chronic kidney disease: A systematic review and network meta-analysis

(2017) Giuseppe Andò et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA 2 DS 2 -VASc score in the entire Korean population

(2017) So-Ryoung Lee et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials

(2017) George Ntaios et al.   International Journal of Stroke

When Less Is Not More ∗

(2017) Sean D. Pokorney et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease

(2017) Giulia Renda et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial

(2017) Raffaele De Caterina et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction

(2017) Xiaoxi Yao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The ABC pathway: an integrated approach to improve AF management

(2017) Gregory Y. H. Lip   Nature Reviews Cardiology

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

(2017) Christopher P. Cannon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

(2017) Charles V. Pollack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation

(2017) Hugh Calkins et al.   NEW ENGLAND JOURNAL OF MEDICINE

Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study

(2017) So-Ryoung Lee et al.   PLoS One

Is There an Obesity Paradox for Outcomes in Atrial Fibrillation?

(2017) Marco Proietti et al.   STROKE

Restarting Anticoagulant Therapy After Intracranial Hemorrhage

(2017) Santosh B. Murthy et al.   STROKE

Warfarin Use in Patients With Atrial Fibrillation Undergoing Hemodialysis

(2017) Chang-Yun Yoon et al.   STROKE

CHA 2 DS 2 -VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke

(2017) Tae-Hoon Kim et al.   STROKE

CHA 2 DS 2 -VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65–74, Female) for Stroke in Asian Patients With Atrial Fibrillation

(2017) Tae-Hoon Kim et al.   STROKE

Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

(2017) Jean Collet et al.   THROMBOSIS AND HAEMOSTASIS

Adherence to oral anticoagulant therapy in patients with atrial fibrillation

(2017) Roberto Cangemi et al.   THROMBOSIS AND HAEMOSTASIS

Associations of Abdominal Obesity and New‐Onset Atrial Fibrillation in the General Population

(2017) Yong‐Soo Baek et al.   Journal of the American Heart Association

Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?

(2017) Ling Kuo et al.   Journal of the American Heart Association

Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation

(2017) Peter Brønnum Nielsen et al.   JAMA Internal Medicine

Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart DiseaseClinical Perspective

(2016) Michael D. Ezekowitz et al.   CIRCULATION

Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial HemorrhageCLINICAL PERSPECTIVE

(2016) Tze-Fan Chao et al.   CIRCULATION

Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

(2016) Dominick J. Angiolillo et al.   Circulation-Cardiovascular Interventions

The Complex Role of Anticoagulation in Cirrhosis: An Updated Review of Where We Are and Where We Are Going

(2016) Tawfik Khoury et al.   DIGESTION

Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation

(2016) N. M. Intagliata et al.   DIGESTIVE DISEASES AND SCIENCES

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians?

(2016) Tze-Fan Chao et al.   HEART RHYTHM

Relation of the SAMe-TT 2 R 2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials

(2016) Marco Proietti et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Underweight is a risk factor for atrial fibrillation: A nationwide population-based study

(2016) Si-Hyuck Kang et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Association of smoking with the risk of incident atrial fibrillation: A meta-analysis of prospective studies

(2016) Wengen Zhu et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity

(2016) Volker Lauschke et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation

(2016) Chern-En Chiang et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Exercise Capacity and Atrial Fibrillation Risk in Veterans

(2016) Charles Faselis et al.   MAYO CLINIC PROCEEDINGS

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

(2016) C. Michael Gibson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence

(2016) Pak Hei Chan et al.   PLoS One

Use of Antithrombotic Therapy and Long-Term Clinical Outcome Among Patients Surviving Intracerebral Hemorrhage

(2016) Tobias Pilgaard Ottosen et al.   STROKE

Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events

(2016) Natalia S. Rost et al.   STROKE

Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial

(2016) Eri Toda Kato et al.   Journal of the American Heart Association

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation

(2016) Xiaoxi Yao et al.   Journal of the American Heart Association

Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study

(2016) Peter Brønnum Nielsen et al.   Scientific Reports

The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective ‘Real-world’ Inception Cohort Study

(2015) Vanessa Roldán et al.   AMERICAN JOURNAL OF MEDICINE

Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart DiseaseCLINICAL PERSPECTIVE

(2015) Alvaro Avezum et al.   CIRCULATION

Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and BleedingCLINICAL PERSPECTIVE

(2015) Peter Brønnum Nielsen et al.   CIRCULATION

Target Intensity of Anticoagulation With Warfarin in Japanese Patients With Valvular Atrial Fibrillation

(2015) Eitaro Kodani et al.   CIRCULATION JOURNAL

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation

(2015) Riccardo Cappato et al.   EUROPEAN HEART JOURNAL

The CHADS2 and CHA2DS2-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis

(2015) Qinmei Xiong et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation

(2015) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Time to Cost-Effectiveness Following Stroke Reduction Strategies in AF

(2015) Vivek Y. Reddy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?

(2015) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation

(2015) David R. Holmes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation

(2015) Rajeev K. Pathak et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort

(2015) Rajeev K. Pathak et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study

(2015) A. Gorst-Rasmussen et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Idarucizumab for Dabigatran Reversal

(2015) Charles V. Pollack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity

(2015) Deborah M. Siegal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation

(2015) Kang-Ling Wang et al.   STROKE

Adherence to dabigatran therapy and longitudinal patient outcomes: Insights from the Veterans Health Administration

(2014) Supriya Shore et al.   AMERICAN HEART JOURNAL

SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation

(2014) Pilar Gallego et al.   AMERICAN JOURNAL OF MEDICINE

Novel Oral Anticoagulants in Patients With Renal Insufficiency: A Meta-analysis of Randomized Trials

(2014) Partha Sardar et al.   CANADIAN JOURNAL OF CARDIOLOGY

Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management

(2014) Luigi Di Biase et al.   CIRCULATION

Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

(2014) Jonathan L. Halperin et al.   CIRCULATION

Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013)

(2014)   CIRCULATION JOURNAL

Stratifying the Risks of Oral Anticoagulation in Patients With Liver Disease

(2014) Lydia M. Efird et al.  

Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis

(2014) Peter Brønnum Nielsen et al.   Clinical Research in Cardiology

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

(2014) S. Halvorsen et al.   EUROPEAN HEART JOURNAL

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial

(2014) Günter Breithardt et al.   EUROPEAN HEART JOURNAL

What is ‘valvular’ atrial fibrillation? A reappraisal

(2014) Raffaele De Caterina et al.   EUROPEAN HEART JOURNAL

Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis

(2014) Tze-Fan Chao et al.   HEART RHYTHM

Percutaneous Left Atrial Appendage Occlusion for Stroke Prophylaxis in Nonvalvular Atrial Fibrillation

(2014) Navkaranbir Singh Bajaj et al.   JACC-Cardiovascular Interventions

Alcohol Consumption and Risk of Atrial Fibrillation

(2014) Susanna C. Larsson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation

(2014) Rajeev K. Pathak et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy

(2014) David R. Holmes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Using the CHA2DS2-VASc Score for Refining Stroke Risk Stratification in ‘Low-Risk’ Asian Patients With Atrial Fibrillation

(2014) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban

(2014) Graeme J. Hankey et al.   STROKE

A specific antidote for dabigatran: functional and structural characterization

(2013) F. Schiele et al.   BLOOD

Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor

(2013) Dagmar Kubitza et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin

(2013) Stavros Apostolakis et al.   CHEST

Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature

(2013) Stefan H. Hohnloser et al.   EUROPACE

Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review

(2013) Oliver P Guttmann et al.   HEART

Alcohol intake and prognosis of atrial fibrillation

(2013) Thure Filskov Overvad et al.   HEART

Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation

(2013) Hany S. Abed et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Adherence to anticoagulant treatment with dabigatran in a real-world setting

(2013) S. Schulman et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

(2013) Willem JM Dewilde et al.   LANCET

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa

(2013) Genmin Lu et al.   NATURE MEDICINE

Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

(2013) John W. Eikelboom et al.   NEW ENGLAND JOURNAL OF MEDICINE

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF

(2012) Graeme J Hankey et al.   LANCET NEUROLOGY

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

(2012) J Donald Easton et al.   LANCET NEUROLOGY

Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran

(2012) Robert G. Hart et al.   STROKE

A randomized study of the effects of exercise training on patients with atrial fibrillation

(2011) Philip Samuel Osbak et al.   AMERICAN HEART JOURNAL

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

(2011) John W. Eikelboom et al.   CIRCULATION

Safety of Percutaneous Left Atrial Appendage Closure

(2011) Vivek Y. Reddy et al.   CIRCULATION

Smoking and incidence of atrial fibrillation: Results from the Atherosclerosis Risk in Communities (ARIC) Study

(2011) Alanna M. Chamberlain et al.   HEART RHYTHM

The Coagulopathy of Chronic Liver Disease

(2011) Armando Tripodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial

(2010) Hans-Christoph Diener et al.   LANCET NEUROLOGY

Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis

(2009) J. Abdulla et al.   EUROPACE

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

(2009) David R Holmes et al.   LANCET

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Physical Activity and Incidence of Atrial Fibrillation in Older Adults

(2008) Dariush Mozaffarian et al.   CIRCULATION

Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation

(2008) Yi Wan et al.